Dr Lal PathLabs

Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Market expert Sanjiv Bhasin has suggested five stocks for investors and medium-term outlook traders for August in the pharmaceutical segment.